Ozone-Depleting Chemicals Led 20th Century Arctic Warming: Study

Chlorofluorocarbons and other substances were banned in 1989 under the Montreal Protocol.

Written byLisa Winter
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, AVSTRALIAVASIN

In addition to causing a hole in the ozone layer above Antarctica, ozone-depleting substances are responsible for half of all Arctic warming between 1955 and 2005, according to a paper published yesterday (January 20) in Nature Climate Change. The findings may help explain why the Arctic is warming at a much faster rate than the rest of the planet, an observation that has long baffled scientists.

Ozone-depleting substances (ODS) are manmade chemicals such as chlorofluorocarbons (CFCs) that first widely emerged in the 1920s for use in refrigerants, aerosol propellants, and solvents. In the early 1980s, scientists became aware that these substances were responsible for the damage to the ozone layer. By 1989, under the Montreal Protocol, the products had been globally banned from use.

Because the Arctic is losing ice at a worrying pace, the researchers sought to find why the area is warming so much ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies